Currently out of the existing stock ratings of Naz Rahman, 17 are a BUY (80.95%), 4 are a HOLD (19.05%).

Naz Rahman

Work Performance Price Targets & Ratings Chart

Analyst Naz Rahman, currently employed at MAXIM GROUP, carries an average stock price target met ratio of 20.83% that have a potential upside of 13.68% achieved within 36 days.

Naz Rahman’s has documented 36 price targets and ratings displayed on 8 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on PALI, Palisade Bio at 13-Nov-2024.

Wall Street Analyst Naz Rahman

Analyst best performing recommendations are on VKTX (VIKING THERAPEUTICS).
The best stock recommendation documented was for VKTX (VIKING THERAPEUTICS) at 2/8/2024. The price target of $50 was fulfilled within 19 days with a profit of $21.11 (73.07%) receiving and performance score of 38.46.

Average potential price target upside

CRXT Clarus Therapeutics Holdings PCSA Processa Pharmaceuticals VKTX Viking Therapeutics PALI Palisade Bio QNRX Quoin Pharmaceuticals Ltd DRC SCPH Scpharmaceuticals AGRX Agile Thrpe VRTX Vertex Pharmaceuticals

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date

Price targets met ratio

Average potential upside

Average Time (Days) For PT To Be Met

Performance score

Hold

2 years 2 months 29 days ago
(23-Aug-2022)

0/1 (0%)

$8.35 (228.77%)

Hold

$13

2 years 2 months 30 days ago
(22-Aug-2022)

0/1 (0%)

$8.7 (202.33%)

Buy

$10

2 years 6 months 4 days ago
(17-May-2022)

0/1 (0%)

$4.78 (91.57%)

Buy

$12

2 years 7 months 10 days ago
(11-Apr-2022)

0/1 (0%)

$3.91 (48.33%)

Buy

$20

2 years 7 months 10 days ago
(11-Apr-2022)

0/1 (0%)

$11.91 (147.22%)

Show more analysts

To gain access for the analyst/ stock price target chart please use a computer

Which stock is Naz Rahman is most bullish on?

Potential upside of $70.42 has been obtained for VKTX (VIKING THERAPEUTICS)

Which stock is Naz Rahman is most reserved on?

Potential downside of $5.48 has been obtained for PALI (PALISADE BIO)

What Year was the first public recommendation made by Naz Rahman?

On 2021

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?